FDA’s Approval of Biogen’s New Alzheimer’s Drug Has Huge Cost Implications for Medicare and Beneficiaries
This brief analyzes the cost implications for Medicare and beneficiaries associated with Biogen’s new FDA-approved Alzheimer’s drug, which will cost $56,000 per year.
Recent and Anticipated Actions to Reverse Trump Administration Section 1557 Non-Discrimination Rules
The Biden Administration has started taking steps to reverse Trump Administration policy and regulations that significantly narrowed the implementation and administrative enforcement of Section 1557, the ACA’s nondiscrimination provision. …More
This brief explores factors contributing to poor mental health and substance use outcomes among children during the pandemic, highlighting groups of children who are particularly at risk and barriers to accessing child and adolescent mental health care.
This brief discusses the role that mothers play in managing children’s health care needs and mothers’ attitudes and concerns about COVID-19 vaccinations.
THE CONVERSATION / LA CONVERSACIÓN expands to address information needs about the COVID-19 vaccines in the Latinx community with new videos featuring doctors, nurses and promotoras (community health workers) in English and Spanish. Produced by KFF (Kaiser Family Foundation) under its Greater Than COVID public information response, the campaign is presented with UnidosUS. Previous messaging featured Black health care workers. YouTube/Google, Facebook, Twitter and Pinterest are supporting distribution.Read More